Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation
- 1 October 2012
- journal article
- research article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 153 (6) , 879-882
Abstract
We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells.Keywords
This publication has 9 references indexed in Scilit:
- Mitochondrial Peroxiredoxin III is a Potential Target for Cancer TherapyInternational Journal of Molecular Sciences, 2011
- Peroxiredoxin 6: A Bifunctional Enzyme with Glutathione Peroxidase and Phospholipase A 2 ActivitiesAntioxidants & Redox Signaling, 2011
- Multiple Functions of Peroxiredoxins: Peroxidases, Sensors and Regulators of the Intracellular Messenger H 2 O 2 , and Protein ChaperonesAntioxidants & Redox Signaling, 2011
- Peroxiredoxin 6 Overexpression Attenuates Cisplatin-Induced Apoptosis in Human Ovarian Cancer CellsCancer Investigation, 2010
- Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism☆Free Radical Biology and Medicine, 2005
- Role of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine MacrophagesCirculation Research, 2004
- Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide SignalingScience, 2003
- Role of Peroxiredoxins in Regulating Intracellular Hydrogen Peroxide and Hydrogen Peroxide-induced Apoptosis in Thyroid CellsJournal of Biological Chemistry, 2000
- Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cellsBritish Journal of Cancer, 1997